A review of ocular drug delivery platforms and drugs for infectious and noninfectious uveitis: The past, present, and future

Christopher D. Conrady, Steven Yeh

Research output: Contribution to journalReview articlepeer-review

2 Scopus citations

Abstract

Uveitis refers to a broad group of inflammatory disorders of the eye that often require medical and surgical management to improve or stabilize vision and prevent vision-threatening pathological changes to the eye. Drug delivery to the eye to combat inflammation and subsequent complications from uveitic conditions is complex as there are multiple barriers to absorption limiting availability of the needed drug in the affected tissues. As such, there has been substantial interest in developing new drugs and drug delivery platforms to help reduce intraocular inflammation and its complications. In this review, we discuss the challenges of drug delivery, novel technologies recently approved for uveitis patient care and promising drug delivery platforms for uveitis and sequelae of ocular inflammation.

Original languageEnglish (US)
Article number1224
JournalPharmaceutics
Volume13
Issue number8
DOIs
StatePublished - Aug 2021

Keywords

  • Drug delivery
  • Eye
  • Inflammation
  • Uveitis

ASJC Scopus subject areas

  • Pharmaceutical Science

Fingerprint

Dive into the research topics of 'A review of ocular drug delivery platforms and drugs for infectious and noninfectious uveitis: The past, present, and future'. Together they form a unique fingerprint.

Cite this